中西医结合治疗90例反流性食管炎的临床疗效观察  

Clinical efficacy of the combination of Chinese and Western medicine in the treatment of 90 cases of reflux esophagitis

作　　者：谢燕[1] 茅靖 XIE Yan;MAO Jing(Department of General Medicine,Songjiang Branch of Shuguang Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 201600,China)

机构地区：[1]上海中医药大学附属曙光医院松江分院内科,上海201600

出　　处：《上海医药》2023年第7期22-24,共3页Shanghai Medical & Pharmaceutical Journal

摘　　要：目的:观察西医联合中药协定方治疗反流性食管炎患者的临床疗效。方法:将90例反流性食管炎患者随机分成研究组和对照组,各45例。对照组予以奥美拉唑、莫沙必利、铝碳酸镁片3种药物进行联合用药治疗,研究组则在对照组患者的治疗基础上给予中药协定方(加味左金丸)进行治疗,比较两组的临床疗效。结果:研究组中医症状评分、不良反应发生率低于对照组;总有效率高于对照组(P<0.05)。结论:在西医常规的抑酸、促胃动力及胃黏膜保护等治疗基础上辅以中药协定方治疗反流性食管炎临床疗效较好,有一定的临床推广价值。Objective:To observe the clinical efficacy of Western medicine combined with herbal protocols in the treatment of patients with reflux esophagitis.Methods:Ninety patients with reflux esophagitis were randomly divided into a study group and a control group with 45 cases each.The control group was treated with a combination of three drugs,including omeprazole,mosapride and magnesium aluminum carbonate tablets,while the study group was treated with the traditional Chinese medicine prescription(Jiawei Zuojin pill)besides the therapy for the control group.The efficacy was compared between the two groups.Results:The traditional Chinese medical syndrome score and the incidence of adverse events were lower,and the overall efficacy was higher in the study group than the control group(P<0.05).Conclusion:This therapy that is supplemented by traditional Chinese medicine prescription based on the conventional treatment of acid suppression,gastric motility and gastric mucosal protection in Western medicine for the treatment of reflux esophagitis has good clinical effect and a certain clinical promotion value.

关 键 词：反流性食管炎 中西医结合 加味左金丸 临床疗效 

分 类 号：R289.5[医药卫生—方剂学] R259[医药卫生—中药学]